» Articles » PMID: 39063621

The Contemporary Role of Salvage Radical Prostatectomy in the Management of Recurrent Prostate Cancer: An Up-to-Date Review

Abstract

Prostate cancer is the second most common cancer among men, with many treatment modalities available for patients, such as radical prostatectomy, external beam radiotherapy, brachytherapy, high-intensity focused ultrasound, cryotherapy, electroporation and other whole-gland or focal ablative novel techniques. Unfortunately, up to 60% of men with prostate cancer experience recurrence at 5 to 10 years. Salvage radical prostatectomy can be offered as an option in the setting of recurrence after a primary non-surgical treatment. However, the complexity of salvage radical prostatectomy is considered to be greater than that of primary surgery, making it the least popular treatment of choice. With the wide use of robotic platforms in urologic oncologic surgery, salvage radical prostatectomy has attracted attention again because, compared to past data, modern series involving salvage Robot-Assisted Radical Prostatectomy have shown promising results. In this narrative literature review, we comprehensively examined data on salvage radical prostatectomy. We investigated the correlation between the different types of primary prostate cancer therapy and the following salvage radical prostatectomy. Furthermore, we explored the concept of a robotic approach and its beneficial effect in salvage surgery. Lastly, we emphasized several promising avenues for future research in this field.

References
1.
Valerio M, Ahmed H, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R . The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2013; 66(4):732-51. PMC: 4179888. DOI: 10.1016/j.eururo.2013.05.048. View

2.
Bhat K, Nathan A, Moschovas M, Nathan S, Patel V . Outcomes of salvage robot-assisted radical prostatectomy in patients who had primary focal versus whole-gland ablation: a multicentric study. J Robot Surg. 2023; 17(6):2995-3003. DOI: 10.1007/s11701-023-01738-0. View

3.
Roach 3rd M, Hanks G, Thames Jr H, Schellhammer P, Shipley W, Sokol G . Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006; 65(4):965-74. DOI: 10.1016/j.ijrobp.2006.04.029. View

4.
van Leeuwen P, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B . (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. BJU Int. 2015; 117(5):732-9. DOI: 10.1111/bju.13397. View

5.
Bates A, Samavedi S, Kumar A, Mouraviev V, Rocco B, Coelho R . Salvage robot assisted radical prostatectomy: A propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol. 2015; 41(11):1540-6. DOI: 10.1016/j.ejso.2015.06.002. View